Stock Chart

FDMT

$12.12 -6.74%
Score: 56.1 HOLD
Pro
Screener
Vol: 0.89x (vs SPY: 1.2x | vs QQQ: 1.3x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 12, 2026
Symmetrical Triangle weak / forming — below our quality gate quality 48/100
A Symmetrical Triangle is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 54% overall; 71% up when formed in a downtrend (n=131)
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About FDMT - 4D Molecular Therapeutics, Inc. Common Stock

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Key Statistics

Market Cap $718M

More FDMT Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This FDMT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track FDMT's price movements with trendlines, gamma walls, and key support/resistance levels.